The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Hedge funds playground.
Clearly both Dec and Jan are both affected by holiday days. Nov was the highest throughput month at 20,000. Average order size is approx £30.
Dec 16.5k, Jan first 20 days 15k.
Product line and marketing effort considerably upgraded.
Hopefully new warehouse facility up and running later this year.
HUD’s growth will require significant management skills .
All orders have an invoice number. Simple sum to compare weeks/months. Currently running ahead of December.
Order throughput in January looks strong.
Investor Meet Company YouTube December 7th. Fusion interim results presentation. CEO and CFO present review and outlook. Towards end CFO states end of November looks similar to October cash flat position.
Last six minutes of video Adrian talks about how valuable Optimal might be to a potential acquirer.
Out of date info. CEO stated recently revenues are now picking up. Oct and Nov there was no cash draw. Company is again recruiting. Target of £15 mn in revenues Pa. Is achievable at some point in the near future, according to Adrian. Lesser companies have been sold for £100 million.
Let’s explore space, Amazon reviews for this product are very positive for the last month. Only US reviews, no UK which is unusual. However still listed at £79.99, no discount. Other similar products have discounted their prices significantly, however they have lower Amazon star ratings.
Confidence returning?
Good results, growing fast and well funded.
Surprising SP weakness today. Profit takers, weak holders or market maker shake out looking for stock?
Sepsis is a horrifying condition, so any company showing any success in its treatment is to be applauded. As Woody says it is difficult to even get to a ballpark figure as to value, but I hope word is getting out that there is a for sale sign up and many interested parties have their calculators humming.